No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

2 Some of these antibodies, called neutralizing antibodies, block the virus from attaching to our cells, thereby effectively preventing infection. 3 In addition to mRNA vaccines, potent antibody ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. Read more at straitstimes.com.

Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...

Vaxxas has announced that the CEPI, has approved the progression of a $7.2 million program to develop heat-stable, ...

Continued development of DPX-mRNA formulations is one of the Company's objectives, with BioVaxys pursuing collaborations with ...